News
Since I’ve been living with psoriasis for over 15 years, you’d think I’d have this disease figured out by now. But when you live with a chronic disease, there will always be curveballs.
The most prominent sign of psoriasis is the appearance of scaly, red patches on the skin. This skin disorder does not have a definitive cure; however, therapy may help alleviate symptoms. In addition, ...
Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...
Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...
This study is the first randomized, double-blind, controlled Phase 3 clinical study evaluating biologics switching in psoriasis patients with prior inadequate response to anti-IL-17 antibody.
The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results